{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-007445","form_type":"8-K","ticker":"VNOV","cik":"0001699709","company_name":"VitaNova Life Sciences Corp","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.181475+00:00","generated_at":"2026-05-17T04:27:38.699905+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Yijia Group proposes name change to VitaNova Life Sciences, reverse split 1:2-1:3","bullets":["Name changed to VitaNova Life Sciences Corporation approved by board and majority of shareholders.","Reverse stock split at ratio 1-for-2 to 1-for-3; ratio still being finalized.","Authorized capital increased to 75M common and 10M preferred shares ($0.0001 par).","Blank check preferred stock created with series, rights, and preferences set by board.","Company intends to file Certificate of Amendment with Nevada Secretary of State after finalizing split ratio."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-007445","json":"https://secwatch.observer/filing/0001683168-25-007445.json","markdown":"https://secwatch.observer/filing/0001683168-25-007445.md","text":"https://secwatch.observer/filing/0001683168-25-007445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699709/000168316825007445/0001683168-25-007445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699709/000168316825007445/yijia_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:27:38.699905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}